CN117530974A - Traditional Chinese medicine for treating intestinal constipation - Google Patents
Traditional Chinese medicine for treating intestinal constipation Download PDFInfo
- Publication number
- CN117530974A CN117530974A CN202311504708.6A CN202311504708A CN117530974A CN 117530974 A CN117530974 A CN 117530974A CN 202311504708 A CN202311504708 A CN 202311504708A CN 117530974 A CN117530974 A CN 117530974A
- Authority
- CN
- China
- Prior art keywords
- constipation
- raw materials
- chinese medicine
- traditional chinese
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 206010010774 Constipation Diseases 0.000 title claims abstract description 72
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 17
- 241001289529 Fallopia multiflora Species 0.000 claims abstract description 16
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 15
- 244000018633 Prunus armeniaca Species 0.000 claims abstract description 15
- 235000009827 Prunus armeniaca Nutrition 0.000 claims abstract description 15
- 235000006533 astragalus Nutrition 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 15
- 235000011477 liquorice Nutrition 0.000 claims abstract description 15
- 241000132012 Atractylodes Species 0.000 claims abstract description 14
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 14
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 14
- 241001061264 Astragalus Species 0.000 claims abstract description 13
- 210000004233 talus Anatomy 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 235000008326 Trichosanthes anguina Nutrition 0.000 claims description 17
- 244000078912 Trichosanthes cucumerina Species 0.000 claims description 17
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 241000213006 Angelica dahurica Species 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 241000125175 Angelica Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 38
- 238000002360 preparation method Methods 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 244000061520 Angelica archangelica Species 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000002040 relaxant effect Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 description 31
- 230000013872 defecation Effects 0.000 description 30
- 208000024891 symptom Diseases 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 238000011084 recovery Methods 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 230000002550 fecal effect Effects 0.000 description 6
- 239000008141 laxative Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 210000001072 colon Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 229940125722 laxative agent Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000001187 pylorus Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000208838 Asteraceae Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000020401 Depressive disease Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 238000000546 chi-square test Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- YPELFRMCRYSPKZ-UHFFFAOYSA-N 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide Chemical compound CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1OCCN(CC=2C=CC(F)=CC=2)C1 YPELFRMCRYSPKZ-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241001083548 Anemone Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000005955 light diet Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229960004085 mosapride Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229940076742 senna leaves Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 55-65g of fructus trichosanthis, 5-7g of angelica, 8-12g of astragalus, 8-12g of raw bighead atractylodes rhizome, 5-7g of polygonum multiflorum, 8-12g of bitter apricot seed, 5-7g of safflower, 5-7g of fried bitter orange and 5-7g of liquorice; mixing the above components, soaking in water, decocting for 1.1 h times the total weight of the raw materials, decocting for 0.5 hr, mixing decoctions, and filtering. The invention has the advantages of rich raw materials, low cost, good effect, simple preparation method, easy production and preparation, and has the effects of relaxing bowel and effectively improving intestinal constipation, stable and reliable curative effect, no toxic or side effect and remarkable social and economic benefits.
Description
Technical Field
The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for treating intestinal constipation.
Background
Constipation refers to a clinical symptom(s) that is manifested by difficulty in defecation and/or reduced number of times of defecation, and dry and hard stool. The difficult defecation comprises difficult defecation, anorectal blockage, incomplete defecation, time-consuming defecation and the need of manual assistance. The reduced number of bowel movements means that bowel movements are <3 times per week. The course of chronic constipation should be more than or equal to 6 months.
At present, a lot of medicines for treating constipation are available, but the common laxatives still take stimulative laxatives as main medicines, the traditional Chinese medicine laxatives often take anthraquinone laxatives such as rheum officinale, senna leaves and the like as main medicines, and western medicine laxatives take diphenols as preparations for multiple purposes. Some health foods also have the effect of relieving habitual constipation, but have higher lazy property and are not suitable for treating constipation. In the prior art, medicines for treating constipation are various, but have weak pertinence and insignificant treatment effect, so that the medicine which is safe and has no toxic or side effect and is suitable for constipation is continuously researched, but related public reports are not found up to the present.
Disclosure of Invention
Aiming at the situation, the invention aims to overcome the defects of the prior art and provide the traditional Chinese medicine for treating the intestinal constipation, which can effectively solve the problem of poor effect of the traditional medicine for treating the intestinal constipation.
In order to achieve the aim, the technical scheme of the invention is that the traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 55-65g of fructus trichosanthis, 5-7g of angelica, 8-12g of astragalus, 8-12g of raw bighead atractylodes rhizome, 5-7g of polygonum multiflorum, 8-12g of bitter apricot seed, 5-7g of safflower, 5-7g of fried bitter orange and 5-7g of liquorice; mixing the above components, soaking in water, decocting for two times, adding water with a volume which is 8 times of the total weight of the raw materials for decocting for 1 h to obtain a first decoction, adding water with a volume which is 6 times of the total weight of the raw materials for decocting for 0.5h to obtain a second decoction, mixing the two decoctions, and filtering to obtain the final product; the weight volume is solids in g and liquids in ml.
The invention has the advantages of rich raw materials, low cost, good effect, simple preparation method, easy production and preparation, and has the effects of relaxing bowel and effectively improving intestinal constipation, stable and reliable curative effect, no toxic or side effect and remarkable social and economic benefits.
Drawings
FIG. 1 is a graph (40X 10) showing the results of HE staining according to the invention.
Detailed Description
The following describes in detail the embodiments of the present invention with reference to the drawings and examples.
The invention, when embodied, is illustrated by the following examples.
Example 1
A traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 55g of snakegourd fruit, 5g of Chinese angelica, 8g of astragalus, 8g of raw bighead atractylodes rhizome, 5g of polygonum multiflorum, 8g of bitter apricot seed, 5g of safflower, 5g of fried bitter orange and 5g of liquorice; mixing the above components, soaking in water, decocting for 1.1 h times the total weight of the raw materials, decocting for 0.5 hr, mixing decoctions, and filtering.
Example 2
A traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 60g of snakegourd fruit, 6g of Chinese angelica, 10g of astragalus, 10g of raw bighead atractylodes rhizome, 6g of polygonum multiflorum, 10g of bitter apricot seed, 6g of safflower, 6g of fried bitter orange and 6g of liquorice, and the preparation method is the same as that of the example 1.
Example 3
A traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 65g of snakegourd fruit, 7g of Chinese angelica, 12g of astragalus, 12g of raw bighead atractylodes rhizome, 7g of polygonum multiflorum, 12g of bitter apricot seed, 7g of safflower, 7g of fried bitter orange and 7g of liquorice, and the preparation method is the same as that of the example 1.
Example 4
A traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 58g of snakegourd fruit, 7g of Chinese angelica, 11g of astragalus, 9g of raw bighead atractylodes rhizome, 5g of polygonum multiflorum, 9g of bitter apricot seed, 6g of safflower, 7g of fried bitter orange and 5g of liquorice, and the preparation method is the same as that of the example 1.
Example 5
A traditional Chinese medicine for treating intestinal constipation is prepared from the following raw materials in parts by weight: 62g of snakegourd fruit, 5g of Chinese angelica, 9g of astragalus, 11g of raw bighead atractylodes rhizome, 6g of polygonum multiflorum, 11g of bitter apricot seed, 5g of safflower, 6g of fried bitter orange and 7g of liquorice, and the preparation method is the same as that of the example 1.
In the above-mentioned medicine, the medicine,
all snakegourd fruit: sweet in flavor, slightly bitter in flavor, cold in nature, enters liver, stomach and large intestine meridians. Belongs to the dry tuber of the cucurbitaceae plant anemone. Has effects of clearing heat, eliminating phlegm, relieving chest stuffiness, resolving hard mass, loosening bowel to relieve constipation, etc. Fructus Trichosanthis can be used for treating cough due to phlegm heat, phlegm nodule, thoracic obstruction, acute appendicitis, acute mastitis, constipation due to intestinal dryness, etc.
Chinese angelica root: sweet and pungent in flavor, warm in nature, and enters liver, heart and spleen meridians. Sweet and moist, pungent and warm in nature, it enters liver and heart meridians and spleen meridians. It is good at replenishing blood and activating blood, regulating menstruation and relieving pain, relaxing bowel and expelling cold, and is suitable for treating constipation due to blood deficiency and blood stasis, especially constipation due to dryness of the intestines, and is not only a key herb for regulating menstruation in gynecology but also a good blood-replenishing product in internal medicine and is commonly used for detumescence and wound therapy in surgery.
Radix astragali: sweet and slightly warm nature, enter spleen and lung meridians. Is dry root of Astragalus mongholicus bge or Astragalus membranaceus bge. Gan Wenbu L, sweet and bland, and good permeability; it is used with mild condition and stir-baked with honey to warm the spleen and lung meridians, strengthen body resistance and remove pathogenic factors. It is good at tonifying middle-jiao qi, promoting the production of qi and clearing yang, tonifying lung qi, invigorating stomach and consolidating exterior, and can be used for treating spleen-lung qi deficiency, sinking of middle-jiao qi, qi failing to control blood, spontaneous perspiration and night sweat, etc., and also for treating sore, carbuncle, non-ulcer or chronic ulcer due to qi and blood deficiency, qi deficiency and edema, dysuria.
Raw white atractylodes rhizome: bai Zhu is bitter, sweet and warm in nature. Enter spleen and stomach meridians. The raw Atractylodis rhizoma is dry rhizome of Atractylodis rhizoma of Compositae. Can strengthen the spleen and replenish qi, and is a good medicine for invigorating qi and strengthening the spleen. Can be used for treating abdominal distention and diarrhea due to spleen qi deficiency and spleen and stomach deficiency cold. Stagnation in the stomach and distention and fullness due to spleen deficiency. Raw Bai Zhu also can dry dampness and promote diuresis and is used for treating phlegm and water swelling and the like. Can be used for treating spontaneous perspiration due to qi deficiency, and preventing miscarriage.
Polygonum multiflorum Thunb: bitter, sweet and astringent in taste and slightly warm. It enters liver, heart and kidney meridians. The deficiency tonifying medicine is dried root tuber of Polygonum multiflorum Thunb of Polygonaceae. It enters liver and kidney meridians and has different actions of making and growing. It is slightly warm in preparation, sweet and astringent in flavor, not greasy and not dry, good in tonifying liver and kidney, replenishing essence and blood, and blackening hair and beard, and is a tonic good herb for deficiency of essence and blood. It has the effects of relieving sore, swelling, scrofula, and constipation due to weakness, promoting the circulation of qi, and tonifying deficiency.
Bitter apricot kernel: bitter and slightly warm; it is slightly toxic. Enter lung and large intestine meridians. Bitter and purgation, rich in fat, slight in temperature and small in toxicity, strong in medicinal efficacy, and enters the lung and large intestine meridians. It can lower lung qi to relieve cough and dyspnea, moisten intestine and dry stool, and also has the actions of ventilating lung to treat various cough and dyspnea and constipation due to intestine dryness.
Safflower: pungent and warm in flavor. It enters heart and liver meridians. Is dried flower of Carthami flos of Compositae. Pungent and dispersed warm are introduced into the heart and liver meridians. It is good at activating blood and resolving stasis, inducing menstruation and relieving swelling and pain, and is indicated for all syndromes of blood stasis with strong medicinal herbs.
Stir-frying fructus aurantii: has pungent and bitter taste, can promote qi circulation and reduce qi, can relieve cough symptoms caused by qi stagnation between chest and abdomen, is a common medicine for clinically treating chest distress and qi stagnation, and has relieving effect on uncomfortable symptoms such as intestinal wind, blood stasis, rubella pruritus, gestational abdominal pain and the like. Has effects in removing food stagnation, relieving stagnation, promoting qi downward, relieving distention, resolving food stagnation, relieving dyspepsia, abdominal pain, abdominal distention, anorexia, etc., and can be used for treating edema, constipation, uterus prolapse, rectocele, etc.
Licorice root: sweet and flat nature, it enters heart, lung, spleen and stomach meridians. Is dry root and rhizome of Glycyrrhiza uralensis Fisch, glycyrrhiza uralensis Fisch or Glycyrrhiza glabra of Leguminosae. Sweet and smooth, and mild, it is effective in promoting the production of flat and cool, and it is effective in treating flat and warm, and it is indicated for spleen and lung meridians, stomach and heart meridians. Not only tonify qi and strengthen middle energizer, but also relieve spasm and pain, alleviate drug properties, and also eliminate phlegm and relieve cough and detoxify. The honey-fried qi-tonifying and urgent-relieving effects are strong; it can purge fire and detoxify.
The invention takes the whole snakegourd fruit and the bitter apricot seed as principal drugs for relaxing bowels, takes safflower as ministerial drugs for dispersing the heat and dredging, astragalus root as sweet and warm tonifying, raw atractylodes macrocephala as qi-tonifying and spleen-strengthening, and takes the fried bitter orange as ministerial drugs for promoting digestion and resolving food stagnation, can relieve dyspepsia, abdominal pain and abdominal distention, inappetence and the like caused by dyspepsia, takes the polygonum multiflorum as good tonic drugs for treating deficiency of essence and blood, takes the angelica and the liquorice as adjuvant drugs, takes the angelica and the liquorice as sweet and moisturizing and tempering drugs, and takes the medicines as messenger drugs. The medicines monarch, minister, assistant and guide are scientifically and reasonably combined, mutually support each other, mutually cooperate, exert the curative effect of the medicines and reduce the side effect on the body.
The traditional Chinese medicine composition disclosed by the invention is prepared scientifically according to the monarch, minister, assistant, guide, strict in compatibility, complementary, stable in quality, good in curative effect, and quite good in beneficial technical effect through experiments, and related experimental data are as follows (taking example 2):
1. animal experiment
1. Materials and methods
1.1 laboratory animals, medicaments and reagents
Experimental animals: male SPF-grade Kunming mice, 60, weighing (20+ -2) g, 6-8 weeks old, were purchased from Si Bei Fu (Beijing) Biotechnology Co. And (3) adaptively feeding for 7 days, and controlling the relative humidity to be 50+/-10% and the temperature to be 23+/-2 ℃ by free diet and drinking water.
1.2 animal model preparation
The constipation model group, the recovery control group and the drug treatment group were given loperamide solution 20mg/kg for 1 time/d for 1 week. The blank group was given an equivalent dose of normal saline for lavage.
1.3 Experimental grouping and administration
The 60 mice were randomly divided into 4 groups of 10 mice each, which were blank group, constipation model group, recovery control group, and drug treatment group. The medicine treatment group was given 0.3ml/10g of the traditional Chinese medicine (snakegourd intestine-moistening soup) prepared in the example 2 for lavage, the control group was recovered to be given 2.5mg/kg of mosapride for lavage, and the blank group and the constipation model group were given equal doses of physiological saline for lavage. Each group was irrigated 1 time/d, followed by 7d.
1.4 fecal moisture content
The fecal water content of the mice after the last drug administration was recorded. Collecting 24-h stool of each group of mice, weighing the wet weight of the stool of the mice, drying by an electrothermal constant-temperature blast drier, immediately taking out the dried weight after reaching the drying standard, measuring the dry weight, calculating the water content, and judging the influence of the snakegourd intestine-moistening soup on constipation of experimental animals.
1.5 intestinal Propulsion
The measurement is carried out by adopting a magenta solution method, after blood is taken from the eyeball, the pylorus is taken out from the cecum immediately after the laparotomy, and the total length of the intestinal canal and the pushing length of the magenta in the intestinal canal are measured under the condition of no tension.
The calculation formula is as follows: small intestine propulsion = (pylorus to red intestine infected distance/pylorus to cecum full length) ×100%.
1.6 hematoxylin-eosin (HE) staining for the observation of colon tissue pathology
Fresh colon tissue of a mouse is taken and fixed by 4% paraformaldehyde fixing solution, and the colon tissue pathological changes are photographed by a microscope through conventional dehydration, wax dipping, embedding, slicing, unfolding, baking and HE staining.
1.7 determination of serum VIP, 5-HT, SS and SP levels
After blood is taken from eyeballs, the eyeballs are centrifuged for 15min at 3500r/min, serum is taken, the levels of VIP, 5-HT, SS and SP in the serum are determined by adopting an ELISA method, and all operations are strictly determined according to the instruction book of the kit.
1.8 statistical methods
Data analysis data processing was performed using SPSS 25.0 software. Experimental data are expressed by mean value +/-standard deviation, single-factor variance analysis is adopted, turkey HSD and LSD methods are selected for analysis and comparison when multiple comparison variances are uniform, tamhane's T test and Dunnet are selected when variances are irregularthe t's T method is used for analysis and comparison, and all statistical tests are performedP<The concentration of 0.05 was found to be significant,P<0.01 is very significant.
2. Results
2.1 Fecal moisture content
The water content of the feces of the mice in the constipation model group is obviously lower than that of the feces in the blank groupP<0.01 Recovery control and drug treatment groups higher than constipation model groupP<0.05,P<0.01). See table 1.
Table 1 fecal moisture content of mice in each group
Grouping | Fecal moisture content |
Blank group | 0.39±0.05 |
Constipation model group | 0.32±0.06** |
Recovery control group | 0.40±0.06** |
Drug treatment group | 0.39±0.06** |
Note that: comparison with blank groupP<0.05, **P<0.01; comparison with constipation model groupP<0.05, **P<0.01
2.2 Intestinal tract propulsion rate
The intestinal propulsion rate of the mice in the constipation model group is obviously lower than that of the mice in the blank groupP<0.01 Recovery of control and drug treatment group heightModel group of constipationP<0.01 And the drug-treated group was higher than the recovery control group. See table 2.
Table 2 intestinal tract propulsion rate of mice of each group
Grouping | Intestinal tract propulsion rate |
Blank group | 0.93±0.03 |
Constipation model group | 0.73±0.14** |
Recovery control group | 0.90±0.06** |
Drug treatment group | 0.92±0.06** |
Note that: comparison with blank groupP<0.05, **P<0.01; comparison with constipation model groupP<0.05, **P<0.01
2.3 Pathological staining of colon
The results are shown in figure 1, the colon mucosa of the blank group has no obvious congestion, edema and erosion, smooth surface and regular glands; the constipation model group can be used for treating mucosal congestion and swelling, the mucosal structure is less clear, the surface is not smooth, and glands are atrophic and disordered; the recovery control group and the drug treatment group have smoother mucous membrane surface, tidy gland arrangement, goblet cell increase and the like. .
2.4 VIP, SS, 5-HT and SP level changes in serum
The VIP and SS levels of the constipation model group are obviously higher than those of the blank groupP<0.05,P<0.01 Restoring the control group and the drug treatment group to be lower than the constipation model groupP<0.05,P<0.01 And the drug-treated group was lower than the recovery control group. Constipation model group 5-HT and SP levels were significantly lower than those of blank groupP<0.01,P<0.05 The recovery control group and the drug treatment group are obviously higher than the constipation model groupP<0.01 And the drug-treated group was higher than the recovery control group. See table 3.
TABLE 3 changes in VIP and SP levels in serum
Grouping | VIP | SS | 5-HT | SP |
Blank group | 137.43±9.75 | 13.24±0.83 | 177.47±18.71 | 20.37±6.04 |
Constipation model group | 152.34±7.04* | 16.17±1.85** | 122.85±25.29** | 12.96±6.07* |
Recovery control group | 135.47±19.93* | 11.91±1.06** | 202.76±33.08** | 20.56±4.93** |
Drug treatment group | 134.00±19.21** | 13.49±1.36** | 235.61±10.74** | 41.12±8.88** |
Note that: comparison with blank groupP<0.05, **P<0.01; comparison with constipation model groupP<0.05, **P<0.01
2. Clinical trials
On the basis of ensuring safety of animal experiments, the effect is very good through clinical trial, and taking constipation with qi constipation as an example, relevant experimental data are as follows:
1. diagnostic criteria:
1.1 Western medicine diagnostic criteria (reference Roman IV functional Constipation diagnostic criteria)
(1) The following 2 or more symptoms must be met:
(1) more than one fourth of the defecation feel hard;
(2) more than one fourth of the excrement is in a dry ball shape or a hard excrement block;
(3) more than one fourth of the defecation feel a sense of incomplete defecation;
(4) more than one-fourth of the bowel movements feel anorectal obstruction or obstruction;
(5) more than one fourth of the defecation needs to be supported by fingers or the basin bottom to assist the defecation;
(6) spontaneous defecation is less than 3 times/week;
(2) Substantially no discharge of a thin stool when no laxative is applied;
(3) Clinical symptoms do not support diagnosis of irritable bowel syndrome;
(4) And constipation caused by organic lesions, medicines and the like of the whole body of the intestinal tract is eliminated.
Clinical symptoms have appeared for 6 months or more, and nearly 3 months symptoms meet the above diagnostic criteria.
1.2 diagnostic criteria of traditional Chinese medicine (refer to the guide 2019 on the basic diagnosis and treatment of chronic constipation)
Constipation refers to a clinical symptom(s) that is manifested by difficulty in defecation and/or reduced number of times of defecation, and dry and hard stool. The difficult defecation comprises difficult defecation, anorectal blockage, incomplete defecation, time-consuming defecation and the need of manual assistance. The reduced number of bowel movements means that bowel movements are <3 times per week. The course of chronic constipation should be more than or equal to 6 months.
1.3 traditional Chinese medicine qi-secret diagnosis standard (refer to the guiding principle of clinical research of new traditional Chinese medicine, the common opinion of medical science of combined diagnosis and treatment of 2017 functional constipation and the combined internal science of Chinese and Western medicine)
Main symptoms are as follows: the defecation is laborious, the defecation is incomplete after defecation, or difficult and unsmooth, dry or not very dry stool, abdominal distending pain and less defecation times;
secondary symptoms: borborygmus and flatulence, anxiety depression or dysphoria and irritability, chest and hypochondrium fullness and distention, frequent eructation and anorexia;
tongue pulse: a red tongue with thin and greasy coating and a wiry pulse.
The main symptoms are indispensable, the secondary symptoms conform to 2 or more reference tongue vessels, and can be diagnosed as qi-secret syndrome.
2. Selection of case criteria
(1) Meets the diagnostic standard of Roman IV functional constipation in modern medicine;
(2) Meets the diagnosis standard of the qi and the secret of the traditional Chinese medicine;
(3) Age between 18 and 65 years old;
(4) Patient compliance was better and voluntarily participated in this study, identifying informed consent.
3. Treatment protocol:
the 64 diagnosed patients with functional constipation (qi constipation) are outpatient patients, and are randomly divided into a treatment group and a control group, wherein each group is divided into 32 persons, the treatment group takes the traditional Chinese medicine (snakegourd fruit intestine-moistening soup) prepared in the example 2 (one dose), the control group takes the four-grinding soup oral liquid, the treatment course is 2 weeks, and the curative effect is evaluated after 2 treatment courses are finished.
During the treatment period, the two groups of patients stop using other medicines for treating constipation, keep happy mood, drink 1.5-2.0L of water every day, drink light diet, avoid spicy stimulation, eat 20-30 g of dietary fiber in proper quantity, take care of rest, do not stay up night, exercise moderately, develop good defecation habit, defecation regularly every day, do not inhibit defecation, and massage abdomen every day.
4. Efficacy assessment:
4.1 efficacy index Observation
(1) Recording the main symptom integral of defecation effort, abdominal distention and pain, falling inexhaustible feeling, defecation frequency, defecation time and fecal character of two groups of patients before and after treatment;
(2) The symptoms and signs of borborygmus, vector qi, anxiety depression or dysphoria, irritability, chest and hypochondrium fullness, belch frequent pattern and anorexia before and after treatment are recorded for the two groups of patients.
4.2 criteria for symptom grading score:
the constipation Chinese medical diagnosis and treatment consensus opinion and the Chinese and Western medical consensus opinion are referred to, and are classified into 0, 1, 2 and 3 according to the severity of the disease, and the main symptoms are respectively classified into 0, 2, 4 and 6. The secondary symptoms were respectively marked as 0, 1, 2 and 3 points. Tongue pulse is not counted as a score due to individual differences.
4.3 constipation efficacy assessment criteria
Referring to the treatment effect evaluation standard of the syndrome in the constipation Chinese medical diagnosis and treatment consensus opinion:
and (3) healing: all qi secret and related symptoms and physical signs disappear or nearly disappear, and the curative effect index n is more than or equal to 95%;
the effect is shown: the qi secret and related symptoms and physical signs are obviously reduced before, and the curative effect index n is more than or equal to 70% and less than 95%;
the method is effective: the qi secret and related symptoms and signs are improved, and the curative effect index n is less than or equal to 30 percent and less than 70 percent;
invalidation: the qi secret and the related symptoms and signs are not improved, even aggravated, and the curative effect index n is less than 30%.
Note that: n= [ (pre-treatment symptom score-post-treatment symptom score)/pre-treatment symptom score ] ×100%.
5. Clinical statistics results:
the 64 diagnosed patients fall off 4 during the treatment course, and finally 60 patients are included in the statistics. 30 of the treatment groups, 13 men and 17 women, age 49.70 + -9.17 years old; 30 control groups, 11 men and 19 women; the ages 50.47 + -8.23 years. There is comparability between the two groups.
After treatment according to the treatment scheme given above, 30 treatment groups had cured 4 (13.33%), 15 (50.00%), 10 (33.33%), 1 (3.33%) and the total effective rate was 96.66%. 30 cases of the control group are cured 1 case (3.33%), 9 cases of obvious effect (30.00%), 14 cases of effective effect (46.67%), 6 cases of ineffective effect (20.00%), and the total effective rate is 80.00%. The effective rate of the treatment group is obviously higher than that of the control group, and no adverse reaction and toxic or side effect are found during the test.
After the treatment is finished for 4 weeks, all patients in the treatment group and the control group are subjected to telephone follow-up, 23 patients in the treatment group have good complaining and defecation conditions, the illness state is not repeated, 5 patients complain of illness state is lightened, the treatment is continued, and 2 patients complain of illness state relapse, and the relapse rate is 6.67%. The 17 patients in the control group have good complaint and defecation conditions, the disease condition is not repeated, the disease condition of 4 patients is relieved, the medicine is continuously taken for treatment, the disease condition of 9 patients is recurred, the recurrence rate is 30.00 percent, and the patients are subjected to chi-square test (chi-square test 2 =0.278, p=0.045) suggests that the snakegourd intestine-moistening soup of the present invention is significantly better than the tetramill soup oral liquid in treating the long-term efficacy in functional constipation.
Meanwhile, the experiment is carried out on the embodiment 2, and the same experiment is carried out on other embodiments, so that the same and similar results as those of the embodiment 2 are obtained, and the results are not listed one by one, so that the invention has good effect and stable and reliable curative effect.
3. Conclusion(s)
In conclusion, the traditional Chinese medicine (snakegourd intestine-moistening soup) for treating intestinal constipation has the advantages of scientific and reasonable component compatibility, abundant raw materials, simple preparation method, low cost, good effect, stable and reliable curative effect, no toxic or side effect, high safety, low cost and the like, has the efficacy of moistening the intestines to relieve constipation and effectively improving constipation, has the advantages of 96.66 percent, has good use value, is easy to popularize and apply, and is a great innovation in medicines for improving intestinal constipation, and economic and social benefits are remarkable.
The technical characteristics and key points of the invention are that the traditional Chinese medicine composition is compatible, the decoction is only one dosage form embodiment, and all dosage forms which are made by adopting equivalent replacement means and are applicable to taking, such as powder (pulvis), granules, pills, tablets, oral liquid, capsules, extract powder and the like, are prepared by adopting the traditional Chinese medicine composition according to the technical scheme which is basically the same as the invention or adopting the traditional Chinese medicine composition to prepare the traditional Chinese medicine composition by adopting a conventional preparation method, and belong to the protection scope of the invention.
Claims (6)
1. The traditional Chinese medicine for treating intestinal constipation is characterized by being prepared from the following raw materials in parts by weight: 55-65g of fructus trichosanthis, 5-7g of angelica, 8-12g of astragalus, 8-12g of raw bighead atractylodes rhizome, 5-7g of polygonum multiflorum, 8-12g of bitter apricot seed, 5-7g of safflower, 5-7g of fried bitter orange and 5-7g of liquorice; mixing the above components, soaking in water, decocting for two times, adding water with a volume which is 8 times of the total weight of the raw materials for decocting for 1 h to obtain a first decoction, adding water with a volume which is 6 times of the total weight of the raw materials for decocting for 0.5h to obtain a second decoction, mixing the two decoctions, and filtering to obtain the final product; the weight volume is solids in g and liquids in ml.
2. The traditional Chinese medicine for treating intestinal constipation according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 55g of snakegourd fruit, 5g of Chinese angelica, 8g of astragalus, 8g of raw bighead atractylodes rhizome, 5g of polygonum multiflorum, 8g of bitter apricot seed, 5g of safflower, 5g of fried bitter orange and 5g of liquorice.
3. The traditional Chinese medicine for treating intestinal constipation according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 60g of snakegourd fruit, 6g of Chinese angelica, 10g of astragalus, 10g of raw bighead atractylodes rhizome, 6g of polygonum multiflorum, 10g of bitter apricot seed, 6g of safflower, 6g of fried bitter orange and 6g of liquorice.
4. The traditional Chinese medicine for treating intestinal constipation according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 65g of snakegourd fruit, 7g of Chinese angelica, 12g of astragalus, 12g of raw bighead atractylodes rhizome, 7g of polygonum multiflorum, 12g of bitter apricot seed, 7g of safflower, 7g of fried bitter orange and 7g of liquorice.
5. The traditional Chinese medicine for treating intestinal constipation according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 58g of snakegourd fruit, 7g of Chinese angelica, 11g of astragalus, 9g of raw bighead atractylodes rhizome, 5g of polygonum multiflorum, 9g of bitter apricot seed, 6g of safflower, 7g of fried bitter orange and 5g of liquorice.
6. The traditional Chinese medicine for treating intestinal constipation according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 62g of snakegourd fruit, 5g of Chinese angelica, 9g of astragalus, 11g of raw bighead atractylodes rhizome, 6g of polygonum multiflorum, 11g of bitter apricot seed, 5g of safflower, 6g of fried bitter orange and 7g of liquorice.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311504708.6A CN117530974A (en) | 2023-11-13 | 2023-11-13 | Traditional Chinese medicine for treating intestinal constipation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311504708.6A CN117530974A (en) | 2023-11-13 | 2023-11-13 | Traditional Chinese medicine for treating intestinal constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117530974A true CN117530974A (en) | 2024-02-09 |
Family
ID=89793211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311504708.6A Pending CN117530974A (en) | 2023-11-13 | 2023-11-13 | Traditional Chinese medicine for treating intestinal constipation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117530974A (en) |
-
2023
- 2023-11-13 CN CN202311504708.6A patent/CN117530974A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103816519A (en) | Spleen-strengthening dampness-removing traditional Chinese medicine composition and preparation method thereof | |
CN104324259A (en) | Pharmaceutical composition for treating hepatitis B and preparation method of pharmaceutical composition | |
CN103142842A (en) | Traditional Chinese medicine for treating diabetes mellitus | |
CN103341092B (en) | Preparation method of powder for treating atrophic vaginitis | |
CN103432485B (en) | Chinese medicinal preparation for treating urinary calculus and preparation method | |
CN103285284B (en) | Medical composition for treating senile vaginitis | |
CN112717113B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and paste formula and application thereof | |
CN104784549A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN114748603A (en) | Medicine-food homologous composition for preventing and treating new coronavirus pneumonia variation or compound yang and application | |
CN117530974A (en) | Traditional Chinese medicine for treating intestinal constipation | |
CN107029084A (en) | A kind of Chinese medicine composition and its pharmaceutical preparation for treating Colon and rectum precancerous lesion and application | |
CN103301353A (en) | Pharmaceutical composition for treating atrophic vaginitis | |
CN103028071A (en) | Traditional Chinese medicine composition for treating diarrhea-dominant irritable bowel syndrome and preparation method of traditional Chinese medicine composition | |
CN109674980A (en) | A kind of Chinese medicine composition and preparation method thereof for treating constipation-predominant of irritable bowel syndrome | |
CN104399002A (en) | Traditional Chinese medicine composition for treating rectal cancer | |
CN104001070A (en) | Traditional Chinese medicine composition for treating constipation | |
CN102908575B (en) | Oral traditional Chinese medicine for treating chronic simple rhinitis and preparation method thereof | |
CN108434287A (en) | A kind of Chinese medicine composition and its preparation method and application | |
CN103860844B (en) | A kind of Chinese medicine preparation for the treatment of chronic colitis and preparation method thereof | |
CN103330867A (en) | Preparation method of powder for treating senile vaginitis | |
CN105749021A (en) | Chinese medicine preparation for treating chronic glomerulonephritis | |
CN105709193A (en) | Artemisia argyi Levl-containing traditional Chinese medicine preparation for treating chronic enteritis and preparation method thereof | |
CN105168847A (en) | Traditional Chinese medicine for treating helicobacter pylori infected peptic ulcer | |
CN105641057A (en) | Medicine composition for treating primary glomerular hematuria caused by failure of spleen to control blood vessels | |
CN105435099A (en) | Traditional Chinese medicine for treating superficial gastritis caused by damp heat in spleen and stomach |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |